Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3162-3164

  Giacometti, Andrea ^a,e   Cirioni, Oscar ^a   Ghiselli, Roberto ^a   Orlando, Fiorenza ^b   D'Amato, Giuseppina ^a   Kamysz, Wojciech ^d   Mocchegiani, Federico ^a   Sisti, Valerio ^a   Silvestri, Carmela ^a   Łukasiak, Jerzy ^d   Rocchi, Marco ^c   Saba, Vittorio ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e Ospedale Regionale Torrette   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; LINEZOLID; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; TEMPORIN A; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DACRON IMPLANT; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GRAFT INFECTION; INFECTION PREVENTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS EPIDERMIDIS;

ACETAMIDES; ANIMALS; ANTI-INFECTIVE AGENTS; BLOOD VESSEL PROSTHESIS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; GLYCOPEPTIDES; MALE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PHARMACEUTICAL SOLUTIONS; POLYETHYLENE TEREPHTHALATES; PROSTHESIS-RELATED INFECTIONS; PROTEINS; RATS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 3342960468     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3162-3164.2004     Document Type: Article

References (19)

1. Balaban, N., A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, Y. Gov, M. S. Del Prete, C. Viticchi, V. Saba, G. Scalise, and G. Dell'Acqua. 2003. In vivo prevention of Staphylococcus epidermidis biofilm by RIP, a quorum sensing inhibitor. J. Infect. Dis. 187:625-630.
2. Bergamini, T. M., J. C. Peyton, and W. G. Cheadle. 1992. Prophylactic antibiotics prevent bacterial biofilm graft infection. J. Surg. Res. 52:101-105.
3. Cirioni, O., A. Giacometti, R. Ghiselli, G. Dell'Acqua, Y. Gov, W. Kamysz, J. Łukasiak, F. Mocchegiani, F. Orlando, G. D'Amato, N. Balaban, V. Saba, and G. Scalise. 2003. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767-771.
4. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilm: a common cause of persistent infections. Science 284:1318-1322.
5. Dailey, C. F., C. L. Dileto-Fang, L. V. Buchanan, M. P. Oramas-Shirey, D. H. Batts, C. W. Ford, and J. K. Gibson. 2001. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:2304-2308.
6. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991, Antimicrobial combinations, p. 432-444. In V. Loria (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
7. Goeau-Brissonniere, O. A., D. Fabre, V. Leflon-Guibout, L. Di Centa, M. H. Nicolas-Chanoine, and M. Coggia. 2002. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J. Vasc. Surg. 35:1260-1263.
8. Henke, P. K., T. M. Bergamini, S. M. Rose, and J. D. Richardson. 1998. Current opinion in prosthetic vascular graft infection. Am. Surg. 64:39-45.
9. McManus, A. T., C. W. Goodwin, and B. A. Pruitt, Jr. 1998. Observations on the risk of resistance with the extended use of vancomycin. Arch. Surg. 133:1207-1211.
10. National Committee for Clinical Laboratory Standards. 2001. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial disk susceptibility test, 7th ed. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Noskin, G. A., F. Siddiqui, V. Stosor, D. Hacek, and L. R. Peterson. 1999. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 43:2059-2062.
13. Paladino, J. A. 2002. Linezolid: an oxazolidinone antimicrobial agent. Am. J. Health Syst. Pharm. 59:2413-2425.
14. Sago, T., Y. Mori, H. Takagi, H. Iwata, K. Murase, Y. Kawamura, and H. Hirose. 2003. Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit. J. Vasc. Surg. 37:169-174.
15. Sahgal, V. S., C. Urban, N. Mariano, F. Weinbaum, J. Turner, and J. J. Rahal. 1995. Linezolid (RP 59500) therapy for vancomycin resistant Enterococcus faecium aortic graft infection: case report. Microb. Drug Resist. 1:245-247.
16. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med. 316:927-931.
17. Simmaco, M., G. Mignogna, and D. Barra. 1998. Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47:435-450.
18. Simmaco, M., G. Mignogna, S. Canofeni, R. Miele, M. L. Mangoni, and D. Barra. 1996. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 242:788-792.
19. Zhao, H., A. C. Rinaldi, A. Di Giulio, M. Simmaco, and P. K. Kinnunen. 2002. Interactions of the antimicrobial peptides temporins with model biomembranes. Comparison of temporins B and L. Biochemistry 41:4425-4436.